Nexalin Technology (NXL) Equity Average (2022 - 2025)
Historic Equity Average for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to $5.4 million.
- Nexalin Technology's Equity Average rose 7010.82% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 7010.82%. This contributed to the annual value of $3.4 million for FY2024, which is 2075.51% down from last year.
- According to the latest figures from Q3 2025, Nexalin Technology's Equity Average is $5.4 million, which was up 7010.82% from $4.1 million recorded in Q2 2025.
- In the past 5 years, Nexalin Technology's Equity Average registered a high of $5.9 million during Q4 2022, and its lowest value of $1.8 million during Q2 2024.
- In the last 4 years, Nexalin Technology's Equity Average had a median value of $3.9 million in 2023 and averaged $3.9 million.
- As far as peak fluctuations go, Nexalin Technology's Equity Average crashed by 5785.98% in 2024, and later surged by 12536.03% in 2025.
- Nexalin Technology's Equity Average (Quarter) stood at $5.9 million in 2022, then tumbled by 45.55% to $3.2 million in 2023, then soared by 34.0% to $4.3 million in 2024, then rose by 24.3% to $5.4 million in 2025.
- Its Equity Average stands at $5.4 million for Q3 2025, versus $4.1 million for Q2 2025 and $3.0 million for Q1 2025.